GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVG) » Definitions » E10

CSPC Pharmaceutical Group (FRA:CVG) E10 : €0.07 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CSPC Pharmaceutical Group's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.015. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.07 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-24), CSPC Pharmaceutical Group's current stock price is €0.7458. CSPC Pharmaceutical Group's E10 for the quarter that ended in Dec. 2023 was €0.07. CSPC Pharmaceutical Group's Shiller PE Ratio of today is 10.65.

During the past 13 years, the highest Shiller PE Ratio of CSPC Pharmaceutical Group was 12.15. The lowest was 9.78. And the median was 10.53.


CSPC Pharmaceutical Group E10 Historical Data

The historical data trend for CSPC Pharmaceutical Group's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group E10 Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.07

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.07

Competitive Comparison of CSPC Pharmaceutical Group's E10

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Shiller PE Ratio falls into.



CSPC Pharmaceutical Group E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CSPC Pharmaceutical Group's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.015/114.7809*114.7809
=0.015

Current CPI (Dec. 2023) = 114.7809.

CSPC Pharmaceutical Group Quarterly Data

per share eps CPI Adj_EPS
200312 0.000 72.808 0.000
200412 0.000 74.488 0.000
200512 0.000 75.666 0.000
200612 0.000 77.793 0.000
200712 0.000 82.911 0.000
200812 0.000 83.956 0.000
200906 0.017 83.615 0.023
200912 0.013 85.386 0.017
201006 0.015 85.886 0.020
201012 0.010 89.289 0.013
201106 0.008 91.612 0.010
201112 0.003 92.885 0.004
201206 0.003 93.495 0.004
201212 0.024 95.237 0.029
201306 0.005 95.984 0.006
201312 0.004 97.624 0.005
201406 0.005 98.200 0.006
201412 0.006 99.000 0.007
201506 0.008 99.500 0.009
201512 0.009 100.600 0.010
201606 0.010 101.400 0.011
201612 0.012 102.600 0.013
201706 0.013 103.100 0.014
201712 0.013 104.500 0.014
201806 0.017 104.900 0.019
201812 0.017 106.500 0.018
201906 0.020 107.700 0.021
201912 0.020 111.200 0.021
202006 0.024 110.400 0.025
202012 0.030 111.500 0.031
202106 0.033 111.769 0.034
202112 0.030 113.108 0.030
202203 0.017 114.335 0.017
202206 0.019 114.558 0.019
202209 0.018 115.339 0.018
202212 0.018 115.116 0.018
202303 0.016 115.116 0.016
202306 0.017 114.558 0.017
202309 0.017 115.339 0.017
202312 0.015 114.781 0.015

Add all the adjusted EPS together and divide 10 will get our e10.


CSPC Pharmaceutical Group  (FRA:CVG) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CSPC Pharmaceutical Group's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=0.7458/0.07
=10.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of CSPC Pharmaceutical Group was 12.15. The lowest was 9.78. And the median was 10.53.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CSPC Pharmaceutical Group E10 Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (FRA:CVG) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.